While most investors are fretting the markets recent contraction, you can be quite confident that "my pal Warren" has a smile on his face, as does Peter Lynch, Ken Heebner, Bill Miller, Bruce Berkowitz, and any number of fellow value investors that know now may be a time of opportunity. That is because they have the experience and understanding to pounce when they have a chance to buy things cheap.

This is the fourth installment of my series to discover just that: cheap stocks. If you would like to get on board from the beginning then review the initial post which screened for stocks with lower than market average P/E ratios, see Serious Money: Market Looks Cheap to Me -- 35 Stocks. In the second installment, I looked at yield and PEG ratios: Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth. Then I moved on to the the P/S and P/CF metrics in Serious Money: Cheapest Stocks Yet -- From 35 to 26, cutting nine stocks.

Is the market overpriced? Maybe it is cheap, or perhaps it is fairly valued. This is the third in a series examining the issue. Still, it has been my contention that it does not make any difference because no matter how the market is valued as a whole, there are plenty of cheap stocks out there to accommodate a large amount of capital allocation even this deep into a bull run.

If you would like to follow along from the beginning, the initial post screened stocks for lower than market average P/E ratios: Serious Money: Market Looks Cheap to Me -- 35 Stocks. In the second installment, I looked at yield and PEG ratios: Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth.

Let's try and reduce the gambling by examining the facts and ignoring what the bulls and bears are chatting up at the moment. We started the process by screening for lower than market average P/E ratios, see: Serious Money: Market Looks Cheap to Me -- 35 Stocks.

Two more important criteria influence today's review: the yield, a favorite of "my pal Warren"; and the price-to-earnings-to-growth (PEG) a focus of Peter Lynch, the retired fund manager extraordinaire of Fidelity's Magellan Fund.

We frequently receive comments that the market is overpriced. Recently one of our active readers commented that the market P/E was 30, which it's not. The actual rate (S&P forecast) has been even higher at times due to the volatile market.

The average should trend closer to the long term P/E of 15.7 in the next few years. However, I have reviewed companies often covered on our site and come up with a list of 35 stocks that have price-to-earning ratios below the long-term average already. I think there are dozens of bargains regardless of the status of the overall market.

Investors should take their profits with E.I. du Pont De Nemours and Co (DD), first recommended on April 22, 2009 at a price of $27.48. A Hold was also placed on DD's shares on November 6, 2009.

Given pharmaceutical and industrial/auto sector headwinds, Du Pont's shares look a bit rich at $32.50.

U.S. stock futures declined Tuesday morning as global growth concerns hit markets following S&P downgrade of Japan's outlook and reports of further tightening in China that could hamper growth. Meanwhile, in the U.S., the Federal Reserve begins its two-day policy meeting on Tuesday, amid several economic indicators due out.

U.S. stocks rose Monday as bargain hunters jumped in. But trading was light as Wall Street awaited news from later in the week regarding the confirmation of Federal Reserve Chairman Ben Bernanke, the State of the Union address and bank regulatory developments. Meanwhile, the earnings season continues to give mixed results, not fully convincing investors a recovery is underway.

Analyst Upgrades

• FBR Capital upgraded New York Community Bancorp (NYB) to outperform from market perform following the FDIC-assisted acquisition of AmTrust. The firm raised its target price on shares to $16 from $11.
• Oppenheimer upgraded Brocade (BRCD) to outperform from perform to reflect valuation, low investor expectations, and the company's potential to gain market share in IP/Ethernet switching. The firm set a target price of $8.50 on shares.
• Stifel Nicolaus upgraded National Health Investors (NHI) to buy from hold following the announcement that the litigation vs. Care Foundation has been dismissed. The firm has a $37 target on the stock.
• American Express (AXP) was upgraded to neutral from underperform at BofA/Merrill.
• ACE Ltd. (ACE) was upgraded to buy from neutral at Goldman.
• Kohl's (KSS) was raised to outperform from neutral at Baird.

Today's big shock came in the figures on unemployment as the rate posted a surprising drop to 10.0% from 10.2%. The second was in non-farm payrolls, which posted a decline of only 11,000 jobs rather than the 100,000 expected. Factory orders posted yet another gain as well. Yet the dollar strength caused a reversal of the immediate gains and the markets backed off of the early gap-up levels earlier in the day. Shares were mostly higher at the end of the day but the feeling was one of disappointment that more buying was not out there after the great jobs news.

Here were the unofficial closing bell levels:

Top 10 Analyst Calls
Top Day Trader Stocks

I'm placing a Hold on shares E.I. du Pont De Memours (NYSE: DD), also known as Du Pont, first recommended on April 22, 2009 at a price of $27.48. If you bought DD in April, you're up about 20%

Look for DD's coatings and color technologies business to begin to recover in 2010, on the U.S./global recoveries. However, DD's pharmaceuticals unit will face a tougher 2010, due to patent expirations. The First Call FY2009/FY2010 EPS estimates for DD are $2.01 to $2.22.

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Altria Group Inc. (NYSE: MO) Q3 earnings beat by a penny but sales fell short of expectations; shares fell.
• AMR Corp. (NYSE: AMR) reported a Q3 net loss and plunging revenue but also raised $4 billion in cash.
• BB&T Corp. (NYSE: BBT) topped Q3 earnings expectations but said bad-loan provisions nearly doubled.
• Boeing Co. (NYSE: BA) missed estimates and posted a Q3 loss due to delays for a couple of jet products.
• Capital One Financial Corp. (NYSE: COF) shares rose after it reported better-than-expected Q3 numbers.
• Coca-Cola Co. (NYSE: KO) posted a better-than-expected Q3 profit but sales fell short, and shares fell.

U.S. stocks stocks are poised for a mild open Tuesday morning, a day after U.S. markets already set new 2009 highs and following solid results from Apple (NYSE: AAPL) and Texas Instruments (NYSE: TXN) late Monday. A flood of earnings from such heavyweights as Coca-Cola (NYSE: KO), Pfizer (NYSE: PFE) and DuPont (NYSE: DD) is also due out this morning. In addition, some economic releases, including inflation and housing data, are scheduled for this morning.

More here: Before the bell: Stock futures higher as earnings generally top estimates

Palm (NASDAQ: PALM) closed at $16.45. PALM's Pixi product is expected to be available at Sprint (NYSE-S) before the holidays. PALM November option implied volatility is at 67, January is at 75; verses its 26-week average of 78, according to Track Data, suggesting decreasing near term price movement.

DuPont(NYSE: DD) closed at $34.10. DD is expected to report Q3 EPS on October 20. DD November option implied volatility is at 35; January is at 36; below its 26-week average 40 according to Track Data, suggesting decreasing price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

"The Dogs of the Dow strategy has a long-term history of outperforming the Dow Jones average," notes technical expert Gerald Appel.

In his Systems & Forecasts, he explains, "The theory is that the highest yielding stocks are undervalued and should have the greatest change of appreciating." Here, he reviews the five highest yielders.

"In calculating a formal track record for the strategy, dividend yields are ranked on the last trading day of each year. However, there is no reason why you are limited to ranking stocks only at the end of the year.

"The current market climate appears favorable for using this strategy to garner investment income, since market risk appears below normal and investment income is getting hard to come by.

Analyst upgrades:

• Citigroup upgraded Capital One (NYSE: COF) to Buy from Hold as it believes the credit cycle is starting to recover for U.S. credit cards and an improving economy will support bank credit stabilization. The firm raised its target on shares to $44 from $28.
• JPMorgan upgraded Morgan Stanley (NYSE: MS) to Overweight from Neutral on valuation and believes the stock market recovery will serve as a catalyst.
• Deutsche Bank upgraded F5 Networks (NASDAQ: FFIV) to Buy from Hold after its channel checks indicated a sooner-than-expected order ramp and stabilizing pricing trends. The firm raised its target on shares to $46 from $39.
• COTT Corp. (NYSE: COT) was upgraded to Buy from Neutral at UBS.
• Blackstone Group (NYSE: BX) was upgraded to Equal Weight from Underweight at Barclays.
• Illinois Tool Works (NYSE: ITW) was upgraded to Conviction Buy from Neutral at Goldman.

Du Pont reported better-than-expected Q2 earnings, but the report nevertheless did not overwhelm institutional investors, who've granted the company only a modest P/E of 14.

Even so, I'm Reiterating my Buy rating for E.I. du Pont de Nemours & Company (NYSE: DD), first recommended on April 22, 2009 at a price of $27.74. Here's why: